FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/06/2026
Voltar para busca
Dado oficial do USPTO
EXOEDIT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
04/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
18/06/2024
Data de registro
03/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/03/2026
Última transação
04/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
CORWIN, CHARLOTTE K
Unidade examinadora
N10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Evox Therapeutics Limited
Representantes
David P. Johnson Workman Nydegger
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparations and substances for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparationsa drug delivery system comprising genetically engineered or purified exosomes for therapeutic use; pharmaceutical preparationsexosomes to deliver protein or nucleic acids or viral vectors for therapy; medicine for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; medical preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for medical purposes for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies in the nature of mitochondrial diseasejoint and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; biological preparations comprising exosome for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations comprising a therapeutic target protein-loadednucleic acid-loaded or virus-loaded exosome for the treatment of genetic diseasesrespiratory diseasescancer; biological reagents for medical use; mixed biological preparations for medical purposes for the prevention and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; mixed biological preparations for the prevention and treatment of infectious diseases; extracellular vesicle-based nucleic acid preparations for therapeutical use for the prevention and treatment of infections or disease for the prevention and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies in the nature of mitochondrial diseasejoint and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; gene therapy productsgene delivery pharmaceuticals; pharmaceutical preparations for gene therapygene editinggenome editing; pharmaceutical preparations for use in gene therapies for the treatment of genetic diseases and disorders
Classe 42
Scientificmedical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services in the field of pharmaceuticals; biological research; clinical research in the field of transformational therapeutics; providing medical research and scientific research information in the field of filtration of exosomes from cultured cells or blood; scientific investigations for medical purposes; scientific laboratory services; medical laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of genetic diseasescancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies such as mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; medical laboratory diagnostics research services; genetic engineering services; genetic research; research in the field of gene editing technology; research in the field of DNA mutation; informationadvisory and consultancy services relating to the aforesaid
Classe 44
Medical services; medical and pharmaceutical consultancy; medical diagnostics; medical analysis for the diagnosis and treatment of persons and medical examinations; medical treatment services; medical screening; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerviral and bacterial based infections and diseases; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies such as mitochondrial diseasejoint and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; informationadvisory and consultancy services relating to the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/05/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/01/2026
PUBO
PUBLISHED FOR OPPOSITION
13/01/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/07/2025
RFNT
REFUSAL PROCESSED BY IB
09/02/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/01/2025
RFRR
REFUSAL PROCESSED BY MPU
22/01/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/12/2024
CNRT
NON-FINAL ACTION WRITTEN
23/12/2024
DOCK
ASSIGNED TO EXAMINER
19/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
22/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/11/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/11/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXOEDIT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.